A

The dosing interval is primarily set to keep plasma levels within the therapeutic window and is therefore chosen in relation to how quickly the drug is eliminated—i.e., its elimination (terminal) half-life. Longer half-life drugs can be given at wider intervals, whereas short half-life drugs require more frequent dosing [Grover & Benet, 2011, PMID 21499748].